TuHURA Biosciences Adopts 2026 Inducement Equity Incentive Plan

What Happened

• TuHURA Biosciences, Inc. announced in an 8-K filed September 16, 2026 that its Board adopted the TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan on September 10, 2026.
• The plan reserves 5,000,000 shares of common stock for issuance to new employees as a material inducement to join the company, and was adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4).
• The plan will be administered by the Board’s Compensation Committee and includes a standard form of inducement stock option agreement approved by the Board.

Key Details

• Adoption date: September 10, 2026; 8‑K filed September 16, 2026.
• Shares reserved: 5,000,000 shares of common stock (par value $0.001).
• Eligible recipients: only individuals who qualify as new-employee inducement grants under Nasdaq Rule 5635(c)(4).
• Award types allowed: nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares/units and other stock-based awards; incentive (ISO) stock options are not permitted.
• Grant authority: awards may be granted only by (i) the Compensation Committee if it is comprised solely of independent directors, or (ii) a majority of the company’s independent directors.

Why It Matters

• This plan gives TuHURA a ready tool to attract and retain key hires by offering equity-based compensation without waiting for shareholder approval, which can speed recruiting for critical roles.
• The reserved 5 million shares represent potential future dilution; investors should monitor future filings for the size, timing and terms of actual grants (which will affect share count and compensation expense).
• The plan’s reliance on Nasdaq Rule 5635(c)(4) and independent director approval sets governance and control limits on who can authorize awards.